{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T04:40:59Z","timestamp":1788237659700,"version":"build-2803163510"},"reference-count":39,"publisher":"BMJ","issue":"6","license":[{"start":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T00:00:00Z","timestamp":1764633600000},"content-version":"unspecified","delay-in-days":31,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"JSPS KAKENHI","award":["25K13590"],"award-info":[{"award-number":["25K13590"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Diab Res Care"],"accepted":{"date-parts":[[2025,11,10]]},"published-print":{"date-parts":[[2025,11]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Dyslipidemia is a major risk factor for cardiovascular disease in type 2 diabetes mellitus (T2DM), but its association with kidney disease progression remains incompletely defined. Although low high-density lipoprotein cholesterol (HDL-C) has been linked to diabetic nephropathy, evidence regarding hard kidney outcomes is limited. We examined the associations between HDL-C and kidney events in patients with T2DM, in comparison with other lipid parameters.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Research design and methods<\/jats:title>\n                    <jats:p>A total of 1,033 patients with T2DM from the Fukushima Cohort Study were included. Participants were followed for kidney events, defined as a \u226550% decrease in estimated glomerular filtration rate (eGFR) or onset of kidney failure requiring kidney replacement therapy, and all-cause mortality over a median follow-up period of 5.3 years. Lipid parameters HDL-C, triglycerides (TG), low-density lipoprotein cholesterol, non-HDL-C, and TG\/HDL-C ratio were categorized into quartiles and evaluated using Cox proportional hazards models, adjusted for age, sex, smoking history, history of cardiovascular disease, body mass index, systolic blood pressure, eGFR, hemoglobin A1c, and proteinuria.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The median patient age was 66 years, 56% were men, and the median eGFR was 68.6\u2009mL\/min\/1.73 m\n                      <jats:sup>2<\/jats:sup>\n                      . After multivariable adjustment, patients in the lowest HDL-C quartile (&lt;42\u2009mg\/dL) had significantly higher risks of kidney events (adjusted HR 2.61, 95%\u2009CI 1.32 to 5.14) and all-cause mortality (adjusted HR 2.27, 95%\u2009CI 1.16 to 4.42) than the reference group (HDL-C 49\u201358\u2009mg\/dL). A U-shaped association was observed between HDL-C and all-cause mortality. Subgroup and sensitivity analyses were consistent. No significant associations were observed for other lipid parameters with either kidney events or mortality.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Low HDL-C levels were independently associated with kidney events and all-cause mortality in patients with T2DM. Future studies are warranted to clarify whether interventions targeting HDL-C can improve kidney disease progression in this high-risk population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>UMIN000040848.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjdrc-2025-005581","type":"journal-article","created":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T18:15:29Z","timestamp":1764785729000},"page":"e005581","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":4,"title":["High-density lipoprotein cholesterol and kidney disease progression in patients with type 2 diabetes mellitus: the Fukushima Cohort Study"],"prefix":"10.1136","volume":"13","author":[{"given":"Kei","family":"Nakada","sequence":"first","affiliation":[{"name":"Department of Nephrology and Hypertension, Fukushima Medical University, Fukushima, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4655-9355","authenticated-orcid":false,"given":"Kenichi","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Hypertension, Fukushima Medical University, Fukushima, Japan"},{"name":"Division of Advanced Community Based Care for Lifestyle Related Diseases, Fukushima Medical University, Fukushima, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2331-215X","authenticated-orcid":false,"given":"Hiroshi","family":"Kimura","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Hypertension, Fukushima Medical University, Fukushima, Japan"},{"name":"Division of Advanced Community Based Care for Lifestyle Related Diseases, Fukushima Medical University, Fukushima, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotaka","family":"Saito","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Hypertension, Fukushima Medical University, Fukushima, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Oda","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Hypertension, Fukushima Medical University, Fukushima, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syuhei","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Hypertension, Fukushima Medical University, Fukushima, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michio","family":"Shimabukuro","sequence":"additional","affiliation":[{"name":"Division of Advanced Community Based Care for Lifestyle Related Diseases, Fukushima Medical University, Fukushima, Japan"},{"name":"Department of Diabetes, Endocrinology and Metabolism, Fukushima Medical University, Fukushima, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Asahi","sequence":"additional","affiliation":[{"name":"Division of Advanced Community Based Care for Lifestyle Related Diseases, Fukushima Medical University, Fukushima, Japan"},{"name":"Division of Nephrology and Hypertension, Iwate Medical University, Yahaba, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsuyoshi","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Division of Advanced Community Based Care for Lifestyle Related Diseases, Fukushima Medical University, Fukushima, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junichiro James","family":"Kazama","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Hypertension, Fukushima Medical University, Fukushima, Japan"},{"name":"Division of Advanced Community Based Care for Lifestyle Related Diseases, Fukushima Medical University, Fukushima, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,12,3]]},"reference":[{"key":"2025120310151473000_13.6.e005581.1","doi-asserted-by":"publisher","DOI":"10.1016\/J.KINT.2023.10.018"},{"key":"2025120310151473000_13.6.e005581.2","unstructured":"Therapy TJSfD . Renal data registry (JRDR) 2023 annual report. Tokyo, Japan The Japanese Society for Dialysis Therapy; 2023."},{"key":"2025120310151473000_13.6.e005581.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2013.07.009"},{"key":"2025120310151473000_13.6.e005581.4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2478\/acph-2025-0002","article-title":"The impact of blood lipids and statins on renal function and mortality in patients with diabetic nephropathy: A meta-analysis","volume":"75","author":"Tian","year":"2025","journal-title":"Acta Pharm"},{"key":"2025120310151473000_13.6.e005581.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2015.12.034"},{"key":"2025120310151473000_13.6.e005581.6","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.V1482084"},{"key":"2025120310151473000_13.6.e005581.7","doi-asserted-by":"crossref","first-page":"407","DOI":"10.5551\/jat.65107","article-title":"Serum High-Density Lipoprotein Cholesterol Levels and the Risk of Kidney Function Decline: The Japan Specific Health Checkups (J\u2011SHC) Study","volume":"32","author":"Kosugi","year":"2025","journal-title":"J Atheroscler Thromb"},{"key":"2025120310151473000_13.6.e005581.8","doi-asserted-by":"crossref","DOI":"10.1186\/s12882-022-02932-2","article-title":"Elevated triglycerides and reduced high-density lipoprotein cholesterol are independently associated with the onset of advanced chronic kidney disease: a cohort study of 911,360 individuals from the United Kingdom","volume":"23","author":"Weldegiorgis","year":"2022","journal-title":"BMC Nephrol"},{"key":"2025120310151473000_13.6.e005581.9","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.011162","article-title":"Association Between Serum High-Density Lipoprotein Cholesterol Levels and Progression of Chronic Kidney Disease: Results From the KNOW-CKD","volume":"8","author":"Nam","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"2025120310151473000_13.6.e005581.10","doi-asserted-by":"publisher","DOI":"10.2337\/dc19-1897"},{"key":"2025120310151473000_13.6.e005581.11","doi-asserted-by":"publisher","DOI":"10.2337\/dc16-1246"},{"key":"2025120310151473000_13.6.e005581.12","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.numecd.2012.05.005","article-title":"High-density lipoprotein cholesterol and the risk of nephropathy in type 2 diabetic patients","volume":"23","author":"Chang","year":"2013","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"2025120310151473000_13.6.e005581.13","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.2337\/diacare.26.7.2150","article-title":"Progression to overt nephropathy in type 2 diabetes: the Casale Monferrato Study","volume":"26","author":"Bruno","year":"2003","journal-title":"Diabetes Care"},{"key":"2025120310151473000_13.6.e005581.14","doi-asserted-by":"publisher","DOI":"10.2337\/dc12-0306"},{"key":"2025120310151473000_13.6.e005581.15","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfr417"},{"key":"2025120310151473000_13.6.e005581.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.numecd.2008.11.003"},{"key":"2025120310151473000_13.6.e005581.17","doi-asserted-by":"crossref","DOI":"10.1186\/s12944-025-02632-4","article-title":"Sex-specific and metabolic subgroup heterogeneity in high-density lipoprotein cholesterol associations with diabetic kidney disease risk: a retrospective cohort study","volume":"24","author":"Wang","year":"2025","journal-title":"Lipids Health Dis"},{"key":"2025120310151473000_13.6.e005581.18","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1038\/s41440-024-01716-5","article-title":"Geriatric Nutritional Risk Index is associated with adverse outcomes in patients with hypertension: the Fukushima Cohort study","volume":"47","author":"Tanaka","year":"2024","journal-title":"Hypertens Res"},{"key":"2025120310151473000_13.6.e005581.19","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1038\/s41598-020-80835-8","article-title":"Xanthine oxidase inhibitors are associated with reduced risk of cardiovascular disease","volume":"11","author":"Saito","year":"2021","journal-title":"Sci Rep"},{"key":"2025120310151473000_13.6.e005581.20","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1007\/s10157-022-02306-w","article-title":"Association of polypharmacy with incidence of CKD: a retrospective cohort study","volume":"27","author":"Kimura","year":"2023","journal-title":"Clin Exp Nephrol"},{"key":"2025120310151473000_13.6.e005581.21","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1007\/s10157-020-02010-7","article-title":"Association between serum potassium levels and adverse outcomes in chronic kidney disease: the Fukushima CKD cohort study","volume":"25","author":"Tanaka","year":"2021","journal-title":"Clin Exp Nephrol"},{"key":"2025120310151473000_13.6.e005581.22","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2008.12.034"},{"key":"2025120310151473000_13.6.e005581.23","first-page":"160","article-title":"Non-HDL cholesterol as a metric of good quality of care: opportunities and challenges","volume":"38","author":"Virani","year":"2011","journal-title":"Tex Heart Inst J"},{"key":"2025120310151473000_13.6.e005581.24","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfad009"},{"key":"2025120310151473000_13.6.e005581.25","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)02074-8"},{"key":"2025120310151473000_13.6.e005581.26","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2024816"},{"key":"2025120310151473000_13.6.e005581.27","doi-asserted-by":"publisher","DOI":"10.1291\/hypres.31.1101"},{"key":"2025120310151473000_13.6.e005581.28","doi-asserted-by":"publisher","DOI":"10.1007\/s13340-020-00439-5"},{"key":"2025120310151473000_13.6.e005581.29","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2015.05.011"},{"key":"2025120310151473000_13.6.e005581.30","doi-asserted-by":"publisher","DOI":"10.1097\/MOL.0b013e328338472d"},{"key":"2025120310151473000_13.6.e005581.31","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26041683","article-title":"High-Density Lipoprotein in Patients with Diabetic Kidney Disease: Friend or Foe?","volume":"26","author":"Liu","year":"2025","journal-title":"Int J Mol Sci"},{"key":"2025120310151473000_13.6.e005581.32","doi-asserted-by":"crossref","DOI":"10.3390\/cells10040764","article-title":"High-Density Lipoproteins and the Kidney","volume":"10","author":"Strazzella","year":"2021","journal-title":"Cells"},{"key":"2025120310151473000_13.6.e005581.33","doi-asserted-by":"publisher","DOI":"10.1038\/nrcardio.2015.124"},{"key":"2025120310151473000_13.6.e005581.34","doi-asserted-by":"publisher","DOI":"10.1124\/pr.58.3.1"},{"key":"2025120310151473000_13.6.e005581.35","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.16179","article-title":"Reconstituted HDL ameliorated renal injury of diabetic kidney disease in mice","volume":"12","author":"Tao","year":"2024","journal-title":"Physiol Rep"},{"key":"2025120310151473000_13.6.e005581.36","doi-asserted-by":"crossref","first-page":"110091","DOI":"10.1016\/j.diabres.2022.110091","article-title":"Effects of pemafibrate on lipid metabolism in patients with type 2 diabetes and hypertriglyceridemia: A multi-center prospective observational study, the PARM-T2D study","volume":"192","author":"Kito","year":"2022","journal-title":"Diabetes Res Clin Pract"},{"key":"2025120310151473000_13.6.e005581.37","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2008.11.010"},{"key":"2025120310151473000_13.6.e005581.38","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.numecd.2021.09.037","article-title":"Low-density lipoprotein cholesterol levels and adverse clinical outcomes in chronic kidney disease: Results from the KNOW-CKD","volume":"32","author":"Lee","year":"2022","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"2025120310151473000_13.6.e005581.39","doi-asserted-by":"crossref","first-page":"641","DOI":"10.5551\/jat.GL2022","article-title":"Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2022","volume":"31","author":"Okamura","year":"2024","journal-title":"J Atheroscler Thromb"}],"container-title":["BMJ Open Diabetes Research &amp; Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjdrc-2025-005581","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T18:15:31Z","timestamp":1764785731000},"score":1,"resource":{"primary":{"URL":"https:\/\/drc.bmj.com\/lookup\/doi\/10.1136\/bmjdrc-2025-005581"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":39,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,12,3]]},"published-print":{"date-parts":[[2025,11]]}},"alternative-id":["10.1136\/bmjdrc-2025-005581"],"URL":"https:\/\/doi.org\/10.1136\/bmjdrc-2025-005581","relation":{},"ISSN":["2052-4897"],"issn-type":[{"value":"2052-4897","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11]]}}}